CORONAVIRUS/Taiwan starts clinical trials of remdesivir on COVID-19 patients
Taipei, March 19 (CNA) Clinical trials of the antiviral drug remdesivir for the treatment of the coronavirus disease COVID-19 have already started in Taiwan, Central Epidemic Command Center (CECC) expert Chang Shang-chun (張上淳) said Thursday.
Speaking at a daily CECC briefing in Taipei, Chang said remdesivir is a highly anticipated drug that many believe could be a potential treatment for COVID-19 patients.
Originally developed by the American drugmaker Gilead Sciences for use against the Ebola virus, remdesivir has been widely discussed as a possible coronavirus treatment, following positive results from Chinese and American doctors who have administered the drug experimentally.
On Jan. 31, Gilead said in a statement that it was working with the Chinese authorities to conduct a clinical trial involving the use of remdesivir on coronavirus patients.
In late February, the CECC announced Taiwanese research teams had successfully synthesized the investigational antiviral drug, and were preparing to carrying out clinical trials on COVID-19 patients in Taiwan.
Health Minister Chen Shih-chung (陳時中), who also heads the CECC, said at the time that Taiwan will set up strict standards for the selection of potential participants in the trials, however the details were not disclosed.
On Thursday, Chang again did not elaborate on which COVID-19 patients would be included in the trials, except to say that they have already begun in Taiwan.
In addition to remdesivir, he revealed that anti-HIV drugs combined with interferons are among the drugs that are been tested on coronavirus patients in the country, noting that local medical experts are also continuing to assess other options for the treatment of COVID-19.
- Member of Taiwan's embassy staff in Honduras contracts COVID-19A member of Taiwan's embassy staff in Honduras was confirmed this week as having contracted the COVID-19 coronavirus, the Ministry of Foreign Affairs (MOFA) said Saturday.05/30/2020 05:26 PM
- Taiwan approves remdesivir as COVID-19 medicationTaiwan's health authorities have approved the potential new coronavirus COVID-19 medication remdesivir for treatment of the disease in the country, the Central Epidemic Command ...05/30/2020 04:34 PM
- No new COVID-19 cases reported in Taiwan SaturdayNo new cases of the COVID-19 coronavirus were confirmed in Taiwan on Saturday, leaving the total number of cases at 442 since the pandemic began late last year, according to the ...05/30/2020 02:16 PM
Member of Taiwan's embassy staff in Honduras contracts COVID-1905/30/2020 05:26 PM
Taipei ranked No. 20 on destination wish list: Booking.com05/30/2020 05:18 PM
Taiwan looks to host key event in resumed world badminton tournament05/30/2020 04:55 PM
Taiwan approves remdesivir as COVID-19 medication05/30/2020 04:34 PM
Delta Electronics to acquire Canadian software developer05/30/2020 03:50 PM